Response of Hispanic Puerto Rican Multiple Sclerosis Patients Switched from High Efficacy Therapies to cladribine Tablets in a Real-World Setting

被引：0
|
作者：
Chinea, Angel [1 ]
Vega-Corteguera, Ramon [2 ]
Martinez-Maldonado, Viviana [2 ]
Vicente, Ivonne [2 ]
Navedo-Santos, Jessenia [1 ]
机构：
[1] San Juan MS Ctr, Guaynabo, PR USA
[2] Caribbean Ctr Clin Res, Guaynabo, PR USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1763/1031
引用
收藏
页码：1112 / 1112
页数：1
相关论文
共 50 条
  • [1] Real-world experience of Hispanic Puerto Rican MS patients being treated with cladribine tablets
    Chinea, Angel
    Vicente, Ivonne
    Vega-Corteguera, Ramon
    Burgos, David Carmona
    Martinez-Maldonado, Viviana
    Navedo-Santos, Jessenia
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1016 - 1016
  • [2] A Multicenter Real-World Data of Cladribine Tablets in Patients with Multiple Sclerosis in Turkey
    Koseoglu, Mesrure
    Omerhoca, Sami
    Balci, Fatma Belgin
    Unal, Aysun
    Ozdemir, Zeynep
    Yuksel, Burcu
    Celik, Rabia Gokcen Gozubatik
    Toprak, Ufuk Emre
    Gursoy, Esra Azize
    Icen, Nilufer Kale
    Altunrende, Burcu
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1017 - 1017
  • [3] Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
    Moser, Tobias
    Ziemssen, Tjalf
    Sellner, Johann
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2022, 172 (15-16) : 365 - 372
  • [4] Real-World Outcomes With Cladribine Tablets in People With Relapsing Multiple Sclerosis
    Okuda, Darin
    Livingston, Terrie
    Moog, Tatum
    Smith, Alexander
    Lebson, Lori
    Piette, Elizabeth
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1100 - 1100
  • [5] Safety and Efficacy of Cladribine in Multiple Sclerosis: A Descriptive Study of 151 Patients in a Real-World Setting.
    Bocero Garcia, Antonio
    Lopez Ruiz, Rocio
    Rincon Valencia, Alexandra
    Montero Ramirez, Emilio
    Torres Moral, Alejandro
    Garcia-Soto, Julio Dotor
    Ben-Yelun Insenser, Miriam
    Arzalluz Luque, Joaquin
    Eichau, Sara
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1073 - 1073
  • [6] A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis
    Aerts, S.
    Khan, H.
    Severijns, D.
    Popescu, V.
    Peeters, L. M.
    Van Wijmeersch, B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 892 - 892
  • [7] Real-world experience switching from high-efficacy infusions to cladribine tablets
    Negroski, D.
    Sellers, D.
    Khiabani, A.
    Khiabani, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 844 - 844
  • [8] Cladribine tablets in people with relapsing multiple sclerosis: a real-world multicentric, multinational study
    Adamec, I.
    Jakob, G. Brec
    Rajda, C.
    Drulovic, J.
    Radulovic, L.
    Kes, V. Basic
    Lazibat, I.
    Rimac, J.
    Cindric, I.
    Grzincic, T.
    Abicic, A.
    Barun, B.
    Gabelic, T.
    Gomezelj, S.
    Pekmezovic, T.
    Klivenyi, P.
    Skoric, M. Krbot
    Habek, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 180 - 180
  • [9] Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting
    Rodriguez-Leal, Francisco Alejandro
    Haase, Rocco
    Akguen, Katja
    Eisele, Judith
    Proschmann, Undine
    Schultheiss, Thorsten
    Kern, Raimar
    Ziemssen, Tjalf
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10 : 1 - 11
  • [10] Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience
    Yamout, Bassem I.
    Shatila, Ahmad
    Inshasi, Jihad
    Hassan, Ali Mohammed Ali
    Szolics, Mikolas
    Hassan, Ahmed
    Farw, Ahmed
    Ismail, Ghida
    Zeineddine, Maya
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 379 - 379
12345